Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Continuation Versus Interruption Following Coronary Angiography
NCT03980990Phase 4Unknown
- Sponsor
- University of Saskatchewan
- Start
- Jun 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Saskatchewan. Primary endpoint: Lactic Acidosis. Status: unknown.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03980990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03980990.